Therapeutic prospects of sex hormone receptor signaling in hormone-responsive cancers

Biomed Pharmacother. 2024 Nov:180:117473. doi: 10.1016/j.biopha.2024.117473. Epub 2024 Sep 25.

Abstract

Globally, hormone-responsive cancers afflict millions of people contributing to cancer-related morbidity and mortality. While hormone-responsive cancers overburden patients, their close families, and even health budgets at the local levels, knowledge of these cancers particularly their biology and possible avenues for therapy remains poorly exploited. Herewith, this review highlights the role of sex hormones (estrogens and androgens) in the pathophysiology of hormone-responsive cancers and the exploration of therapeutic targets. Major scientific databases including but not limited to Scopus, PubMed, Science Direct, Web of Science core collections, and Google Scholar were perused using a string of search terms: Hormone-responsive cancers, androgens and cancers, estrogens and cancer, androgen receptor signalling, estrogen receptor signalling, etc.

Keywords: Androgens; Breast cancer; Estrogens; Hepatocellular carcinoma; Hormone-responsive cancer; Prostate cancer.

Publication types

  • Review

MeSH terms

  • Androgens / metabolism
  • Animals
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Estrogens / metabolism
  • Female
  • Gonadal Steroid Hormones / metabolism
  • Humans
  • Neoplasms / drug therapy
  • Neoplasms / metabolism
  • Neoplasms, Hormone-Dependent / drug therapy
  • Neoplasms, Hormone-Dependent / metabolism
  • Neoplasms, Hormone-Dependent / pathology
  • Receptors, Androgen* / metabolism
  • Receptors, Estrogen* / metabolism
  • Signal Transduction* / drug effects

Substances

  • Receptors, Estrogen
  • Receptors, Androgen
  • Estrogens
  • Androgens
  • Antineoplastic Agents, Hormonal
  • Gonadal Steroid Hormones